18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Vasey, P
  • Largillier, R
  • Gropp, M
  • Gebski, V
  • Sandvei, R
  • Elit, Laurie
  • Angleitner-Boubezinek, L
  • Reed, N
  • Pignata, S
  • Ferrero, AM

publication date

  • September 2009